SHIFERMAN GREGORY L. enters SAGE THERAPEUTICS, INC. with 14.97K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/1/2024ACC: 0001562180-24-007489
Officer· See Remarks
Since Nov 2024
14.97K
Baseline shares
100% direct
14.97K
Direct ownership
1 position
26.61K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned14.97K
Total
14.97K direct14.97K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.97K | Direct |
| Total | 14.97K | 14.97K direct |
Derivative Holdings2
Stock Option (Right to buy)
DirectUnderlying security
Common Stock
Underlying shares
20.61K
Shares owned
N/A
Exercise price
22.20
Expiration
—
Exercise window
—
Stock Option (Right to buy)
DirectUnderlying security
Common Stock
Underlying shares
6K
Shares owned
N/A
Exercise price
23.02
Expiration
—
Exercise window
—
Total
Underlying
26.61K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock | 22.20 | — | — | 20.61K | N/A |
| Stock Option (Right to buy) Direct | Common Stock | 23.02 | — | — | 6K | N/A |
| Total | 26.61K | 0.00 | ||||